Sparse pipeline for acromegaly and gigantism treatment limiting market growth, says GlobalData
28 January 2015 | By GlobalData
The acromegaly and gigantism treatment market will expand at a modest Compound Annual Growth Rate (CAGR) of 3.74% from approximately $588 million in 2013 to $707 million by 2018, limited by a sparse pipeline, according to research and consulting firm GlobalData...